UPS
51
-5
MRK
45
4
WYNN
37
4
IR
65
2
EA
36
2
PDCO
57
5
ROK
47
3
ITW
64
2
KSS
42
3
STI
45
10
DIS
54
2
KLAC
59
3
AN
50
7
CHRW
44
2
AAP
23
3
DOV
67
-2
WMT
70
2
GM
55
3
LUV
29
-6
ADM
33
5
UPS
51
-5
MRK
45
4
WYNN
37
4
IR
65
2
EA
36
2
PDCO
57
5
ROK
47
3
ITW
64
2
KSS
42
3
STI
45
10
DIS
54
2
KLAC
59
3
AN
50
7
CHRW
44
2
AAP
23
3
DOV
67
-2
WMT
70
2
GM
55
3
LUV
29
-6
ADM
33
5
Financhill
Back

Celldex Therapeutics Vs. Perspective Therapeutics Industry Stock Comparison

Buy
65

CLDX
Celldex Therapeutics

Last Price:
43.27
Seasonality Move:
-0.32%
Sell
45

CATX
Perspective Therapeutics

Last Price:
13.05
Seasonality Move:
-12.21%
Buy
65
Celldex Therapeutics (CLDX) is a Buy

Is Celldex Therapeutics a Buy, Sell or Hold?

  • The current Celldex Therapeutics [CLDX] share price is $44.16. The Score for CLDX is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • CLDX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $15.10. The Score for CATX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CLDX Stock Price Chart

What is Celldex Therapeutics's stock price today?

  • The Celldex Therapeutics share price today is $44.16
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CLDX is experiencing buying pressure, which is a positive indicator for future bullish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $15.10
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

CLDX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.83 Buy
Relative Strength Index (14 RSI): 67.01 Buy
Chaikin Money Flow: 486521 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.43 - 42.35) Buy
Bollinger Bands (100): (34.44 - 40.66) Buy

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.59 Buy
Relative Strength Index (14 RSI): 53.45 Buy
Chaikin Money Flow: -513975 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.59 - 15.87) Buy
Bollinger Bands (100): (11.58 - 16.14) Buy

CLDX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 42.96 Buy
20-day SMA: 39.74 Buy
50-day SMA: 38.02 Buy
200-day SMA: 38.47 Buy
8-day EMA: 42.31 Buy
20-day EMA: 40.41 Buy
50-day EMA: 38.62 Buy
200-day EMA: 37.37 Buy

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.46 Sell
20-day SMA: 15.2 Sell
50-day SMA: 13.55 Buy
200-day SMA: 11.05 Buy
8-day EMA: 15.43 Sell
20-day EMA: 14.98 Buy
50-day EMA: 14.06 Buy
200-day EMA: 11.43 Buy

Celldex Therapeutics Earnings Growth & CLDX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.18 per share, an increase this year of $0.19 per share, and a decrease next year of $0.66 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.08 per share.

Celldex Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):